Search
Login
Register
Menu
BJMO
Home
News
CongressUpdate
Specials
Links
All
All
BJMO articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Journal issues
>
Lung cancer special, April 2021
Lung cancer special, April 2021
Lung cancer special, April 2021
Previous issue
Next issue
All issues
Subscribe
Interactive PDF
Quickly to
REVIEW ONCOLOGY
PRACTICE GUIDELINES
PHARMACOTHERAPY
RESEARCH
ONCOCASE
ONCOTHESIS
CONGRESS NEWS
REIMBURSEMENT NEWS
Index
SPECIAL
Immunotherapy as first-line treatment for metastatic NSCLC
T. Feys
Targeted therapies for non-metastatic NSCLC
T. Feys
New therapeutic targets in patients with advanced NSCLC
A. Dekker, T. Feys
The changing first-line treatment landscape for patients with ALK-positive NSCLC
T. Feys
Overcoming crizotinib resistance in ROS1-positive NSCLC
T. Feys
Dual EGFR-VEGF strategy in EGFR-mutant NSCLC
T. Feys
Real-world treatment practices for EGFR-mutant NSCLC patients
A. Dekker, T. Feys